We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Articles

Will the UN Reschedule Cannabis This December?

What happens next month, could have long term global effects for drug policy. So what could happen?

Read More

Inside the ACI’s CBD Safety Trial

The Association for the Cannabinoid Industry's (ACI) own Paul Duffy tells Analytical Cannabis why it's crucial CBD companies have their toxicology data ready for next March, and how the ACI's own safety trial can help that happen.

Read More

Testing the (CBD) Water: A Q&A With the Niva Labs’ Kris Marsh

Cannabis drinks are here to stay, but these bubbly mixtures can be tough to test. To find out how labs can best analyze these blunt-like beverages, Analytical Cannabis caught up Kris Marsh, lab director at the Niva Labs.

Read More

Workshop on Heavy Metals in Cannabis by ICP-MS Now Available to View

Check out the talks to get free advice, tips, methods, guidance, troubleshooting and, suggestions on how to optimize the use of ICP-MS for the accurate and validated measurement of heavy metals in cannabis and cannabis-related products.

Read More

Proving CBD’s Safety in the UK

The immediate future of the Europe's CBD market could be in the hands of UK companies, but only if they can first pass their novel foods review from the country's Food Standards Agency.

Read More

Entering the Cannabis-chocolate Matrix

Are thousands of edibles across the US inaccurately labelled? Analytical Cannabis caught up with the CEO of Cw Analytical Laboratories, Dr Robert Martin, to find out.

Read More

The Pros and Cons of Cannabis Ethanol Extraction

Ethanol extraction is the preferred method of many cannabis extractors, but it still has its drawbacks...

Read More

The View From Europe: Is Cannabis Regulation on the Way?

Despite the failure of the German Bundestag to back greater reform in the last week of October, both legislative and legal changes elsewhere have progressed the overall cannabis discussion in Europe significantly, writes Marguerite Arnold.

Read More

The UK Needs Greater Access to Medical Cannabis, And That Can Start With R&D

The UK needs a science-led cannabis industry based around clinical trials and data, writes Robin Emerson, head of corporate social responsibility at Brains Bioceutical.

Read More

 
Advertisement